Aclaris Therapeutics (ACRS)
(Real Time Quote from BATS)
$1.19 USD
+0.01 (0.85%)
Updated Sep 12, 2024 12:18 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | 21.05% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.65 |
Next Year | -0.58 |
EPS (TTM) | -1.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 7.20M | 1.91M | 14.02M | 8.91M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 27.60M | 2.80M | 33.80M | 12.90M |
Low Estimate | 0.63M | 0.63M | 6.41M | 2.53M |
Year ago Sales | 9.28M | 17.57M | 31.25M | 14.02M |
Year over Year Growth Est. | -22.46% | -89.15% | -55.13% | -36.49% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.15 | -0.65 | -0.58 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | 0.24 | -0.11 | -0.66 | -0.53 |
High Estimate | 0.24 | -0.11 | -0.26 | -0.43 |
Low Estimate | -0.18 | -0.19 | -0.77 | -0.88 |
Year ago EPS | -0.41 | -0.30 | -1.55 | -0.65 |
Year over Year Growth Est. | 80.49% | 50.00% | 58.06% | 11.03% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 4 | 3 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.15 | -0.65 | -0.58 |
7 Days Ago | -0.08 | -0.15 | -0.65 | -0.58 |
30 Days Ago | -0.09 | -0.15 | -0.66 | -0.60 |
60 Days Ago | -0.18 | -0.18 | -0.78 | -0.69 |
90 Days Ago | -0.19 | -0.18 | -0.81 | -0.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.15 | -0.66 | -0.58 |
Zacks Consensus Estimate | -0.08 | -0.15 | -0.65 | -0.58 |
Earnings ESP | 0.00% | 0.00% | -1.28% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.24 | -0.30 | -0.41 | NA |
Estimate | -0.19 | -0.28 | -0.37 | -0.48 | NA |
Difference | 0.04 | 0.04 | 0.07 | 0.07 | 0.06 |
Surprise | 21.05% | 14.29% | 18.92% | 14.58% | 17.21% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more